Tuesday, 17 November 2026European Markets

NYXOAH Stock Is 30% Up In The Last 21 Sessions

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(VIANEWS) - Shares of NYXOAH (BEL 20: NYXH.BR) rose by a staggering 30.76% in 21 sessions from €6.21 to €8.12 at 02:22 EST on Monday, after two consecutive sessions in a row of losses. BEL 20 is jumping 0.06% to €3,826.30, following the last session's upward trend.

NYXOAH's last close was €8.12, 52.57% below its 52-week high of €17.12.

About NYXOAH

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Earnings Per Share

As for profitability, NYXOAH has a trailing twelve months EPS of €-1.21.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -23.22%.

Growth Estimates Quarters

The company's growth estimates for the current quarter and the next is a negative 26.9% and a negative 78.9%, respectively.

More news about NYXOAH (NYXH.BR).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

  1. Published before we listed source documents with each article.
  2. Published 24 Apr 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›